INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

Go back to INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962       

(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962